PHAT
Phathom Pharmaceuticals Inc
7.50$
-0.4%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | -20,173.0% | -482.8% | -95.2% | |
| – | – | – | – | – | 84.3% | 1.4% | 0.4% | |
| – | – | – | – | – | 6,601.9% | 43.5% | 16.4% | |
| – | – | – | – | – | -2,000.6% | -27.7% | -7.1% | |
| – | – | – | – | – | 239.6% | 0.2% | 0.1% | |
| – | – | – | – | – | -239.6% | -0.2% | -0.1% | |
| – | – | – | – | – | 5,765.1% | 107.5% | 0.0% | |
| – | – | – | – | – | 53,897.4% | 330.8% | -0.2% | |
| – | – | – | – | – | 33,484.8% | -152.3% | -95.5% | |
| – | – | – | – | – | -20,412.6% | -483.1% | -95.2% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.